On 28/09/2023, Remap Consulting's Managing Directors and Market Access Experts Dr Paul Craddy and Dr Graham Foxon hosted a live webinar, to discuss orphan medicine market access and the growing challenges ahead.
The webinar includes discussions on:
💡 How rare diseases and orphan medicine will be impacted by the EU HTA.
💡 The impact of HUMN legislation on European market access.
💡 Comparing and contrasting different access strategies for orphan drugs.
💡 Parallel scientific advice.
If you have any questions or would like to discuss the topic in more detail, please reach out!
